June 17, 2020 / 11:16 AM / 23 days ago

BRIEF-ProMis Neurosciences & BC Neuroimmunology Announce Progress On Development Of Antibody Test For COVID-19

June 17 (Reuters) - ProMIS Neurosciences Inc:

* PROMIS NEUROSCIENCES AND COLLABORATOR BC NEUROIMMUNOLOGY ANNOUNCE SIGNIFICANT PROGRESS ON DEVELOPMENT OF HIGHLY ACCURATE ANTIBODY TEST FOR COVID-19

* PROMIS NEUROSCIENCES INC - IN VALIDATION TESTING, SEROLOGY ASSAY ACHIEVED ACCURACY COMPARABLE TO THAT OF INDUSTRY LEADERS

* PROMIS NEUROSCIENCES - CURRENT VERSION OF PROMIS-BCNI ANTIBODY TEST ACHIEVES 99.90% SENSITIVITY & 99.50% SPECIFICITY FOR SARS COV-2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below